INNPF
INNOCAN PHARMA CorpPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 16 Innocan Pharma Corp, a Canadian-Israeli pharmaceutical tech company,…
- R Apr 3 Innocan Pharma Corp, a Canadian-Israeli pharmaceutical tech company,…
- X Jul 31 Short interest falls 61.5% to 15
- X Sep 15 Short interest jumps 10706.7% to 1.6K
- X Sep 30 Short interest falls 99.1% to 15
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest 0.0% to 15 shares. 1.0 days to cover.
- TrendDOWNTREND
18% below its 50-day average. New closing low $1.29 on Oct 26.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
2 filings · 0 bullish · 2 bearish- BEARISH F-1/AApr 3, 2026
Innocan Pharma Corp, a Canadian-Israeli pharmaceutical tech company, is conducting an IPO to raise…
Monitor the company's progress in clinical trials and regulatory approvals for its LPT-CBD platform, as successful development could significantly impact its valuation. However, the going concern…
- BEARISH F-1Mar 16, 2026
Innocan Pharma Corp, a Canadian-Israeli pharmaceutical tech company, is conducting an IPO to raise…
Traders should be cautious due to the company's pre-clinical stage, history of losses, going concern qualification, and geopolitical risks. The IPO proceeds will extend the company's runway but do…
All INNPF filing & press-release reports (2)
- F-1/A reportApr 3, 2026
- F-1 reportMar 16, 2026